Immortum - An App for Using Social Media After Death Feb 9, 2012 08:00AM

LONDON, February 9, 2012 /PRNewswire/ --

Maxelerator Ltd, a venture firm announces the launch of Immortum (http://www.immortum.com), a social media site that allows continued social media interactions even after people have died.

Immortum allows people especially those near end of life due to age or illness to store their memories or messages and publish them later including after death. The published messages are posted on their personal blog as well as the facebook wall allowing the users of Immortum to continue their social media interactions with their facebook friends or with general public even after they die.

One of the Immortum users posted a secret message for his yet to be born grand-child which would be delivered when his 5 year old son has a child and that child grows old enough to read (http://www.immortum.com/b.jack.holly.jh). Another user has posted an undisclosed message for her young daughter which would be delivered when she grows up and gets married. (http://www.immortum.com/m.4f327fdbc85a2)

Use of journals or memory boxes has been advised by professionals in palliative care to people close to end of life. Also, it is a common practice for people to entrust their lawyers with letters which are then disclosed posthumously. Immortum has taken these common practices and given it a modern twist by linking it with popular social media concepts like facebook and blogs.

The key feature of Immortum is a Postlife Journal where users can post messages that would be published after death. Immortum also provides a Life Journal, blog and has multiple forums, which are all linked to the facebook wall of the users. The forums cater to difficult topics including death, coping with illnesses and grief management. Immortum is a free service with no usage limits.

Follow Immortum At: http://www.twitter.com/@immortum1

http://www.immortum.com

SOURCE Immortum (www.immortum.com)


Unity Management Group Subsidiary Receives Order and Completes Contract Feb 9, 2012 08:00AM

 

EAST HANOVER, N.J., Feb. 9, 2012 /PRNewswire/ -- Unity Management Group, Inc. (OTC: UYMG) (or "the Company") announced today its wholly owned subsidiary Metropolitan Computing Corporation (or MCC) has completed a maintenance contract on a Presster Tablet Presses at the University of Basel's Department of Pharmaceutical Science. MCC has also received an order for the PZ –O Tablet Press from Neo Performance Materials Company in Toronto Canada (a publicly traded company). Their sister company, Buss and Buss Spezialmetalle in Sagard Germany, has already purchased the same machine.

"The opportunity to work with a large Canadian Company like Neo Performance Materials is another example of our ability to provide products and value-added services to companies utilizing tablet presses in other areas of production," stated Michael Levin Director of Operations for MCC. Mr. Levin continued "Our staff at MCC has a close working relationship with many of the scientists in the Pharmaceutical Science Department at the University of Basel. Our staff will continue to work closely with them on a number of projects to help with research and development. We believe that our Presster Tablet Press is not only unique, but instrumental in the advancement of these new projects, as well as in the pharmaceutical industry. Unity Management Group Inc and MCC will continue to grow these relationships that will help to expand our sales for the coming year."

About Neo Performance Materials Company (a publicly traded company)

Neo Material Technologies Inc. engages in the production, processing, and development of neodymium-iron-boron magnetic powders (neo powders), rare earths, and zirconium based engineered materials, and other metals and their compounds. The company operates through two divisions, Magnequench and Performance Materials. The Magnequench division produces neo powders that are utilized in bonded magnets for micro motors, precision motors, and sensors, as well as for computer storage devices, office automation, automotive, and appliance industries. The Performance Materials division manufactures and distributes a range of rare earth and zirconium-based engineered materials. This division offers cerium, lanthanum, neodymium, yttrium and yttrium-europium coprecipitates, dysprosium, and terbium, which are used in the automotive catalyst, electronics, ceramic, and glass industries. Neo Material Technologies sells its products through a direct sales force and sales agents worldwide. The company was formerly known as AMR Technologies Inc. and changed its name to Neo Material Technologies Inc. in April 2006. Neo Material Technologies Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.

About University Of Basel

Pharmaceutical Sciences deal with the discovery and development of drugs, their manufacturing, mode of action and clinical use. Pharmaceutical Sciences are at the interface between natural sciences and medicine. Research areas covered by currently 7 professorships range from discovery and optimization of new active substances to pharmacological action and side effects of drugs, galenical formulation, and clinical application of drugs. The Department is responsible for the education at the Bachelor, Master and PhD level. Faculty from academia, industry, hospital and public pharmacy train students in all aspects of modern pharmaceutical sciences and patient-oriented pharmacy. The Department offers two Master degrees. The Master in Pharmacy prepares students for careers in the public health area, whereas the Master in Pharmaceutical Sciences is targeted to students planning for a scientific career in industry or academia. The Department of Pharmaceutical Sciences currently comprises 9 research groups with more than 70 co-workers and has an annual budget of 6.7 mio CHF in university funds. In addition, the Department receives substantial support from various foundations, competitive project funding (Swiss National Science Foundation, CTI, European Union, PharmaSwiss, Novartis Research Foundation), and industry.

About Unity Management Group, Inc.

Unity Management Group, a health resource company, will continue to provide innovative physician practice management services that offer high value and significant return on investment for physicians practices and hospitals through its three subsidiary companies: United Healthcare Solutions Inc., Unity Technologies Inc., and United Business Services Inc.

The first subsidiary, Unity Business Services, is a full service management company offering solutions in practice management, billing, staffing, contracting, licensing, credentialing, and accounting. Unity Business Services also offers assistance in HIPAA compliance, marketing, and unique solutions for practice start-ups and new practices.

Unity Technologies Inc. is a complete software solutions company offering billing, electronic medical records, and electronic health records for physicians' offices and hospitals.

United Healthcare Solutions, a national company based in Nevada, is a healthcare company will be providing medical, vision and dental plans, as well as PPO and HMO networks.

For more information please go to our website which can be found at

www.unitymanagementgroup.com        www.mcc-online.com 

Certain information discussed in this press release may constitute forward-looking statements within the Private Securities Litigation Reform Act of 1995 and the federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions at the time made, it can give no assurance that its expectations will be achieved. Readers are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements are inherently subject to unpredictable and unanticipated risks, trends and uncertainties such as the Company's inability to accurately forecast its operating results; the Company's potential inability to achieve profitability or generate positive cash flow; the availability of financing; and other risks associated with the Company's business. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events.

Unity Management Group, Inc. Investor Relations 855-413-0755

SOURCE Unity Management Group, Inc.


Orexigen Therapeutics to Present at Upcoming Conferences Feb 9, 2012 08:00AM

SAN DIEGO, Feb. 9, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will be presenting at two upcoming investor conferences.  The details are as follows:

The 14th Annual BIO CEO & Investor ConferenceDate:  February 13, 2012Time:  1:30pm Eastern TimeLocation:  Waldorf Astoria, New YorkSpeaker:  Michael Narachi, President and Chief Executive Officer

Leerink Swann Global Healthcare ConferenceDate:  February 15, 2012Time:  8:00am Eastern TimeLocation:  Waldorf Astoria, New YorkSpeaker:  Michael Narachi, President and Chief Executive Officer

To listen to the live webcast or a replay of the presentations, please visit the Investor Relations section of the company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Contrave® has completed Phase 3 clinical trials for which a New Drug Application has been submitted and reviewed by the FDA, and the FDA has agreed to a SPA for the Contrave outcomes trial.  The Company's other product candidate, Empatic™, has completed Phase 2 clinical trials. Further information about the Company can be found at www.orexigen.com.

Corporate Contacts: Orexigen

Orexigen

Media

Jay Hagan

Denise Powell

Chief Business Officer

WCG

(858) 875-8673

(510) 703-9491

 

SOURCE Orexigen Therapeutics, Inc.


Oracle Buys Taleo Feb 9, 2012 08:01AM

DUBLIN, CA--(Marketwire - February 09, 2012) - Oracle today announced that it has entered into an agreement to acquire Taleo Corporation (NASDAQ: TLEO), a leading provider of cloud-based talent management for $46.00 per share or approximately $1.9 billion, net of Taleo's cash and debt. Taleo's Talent Management Cloud helps organizations attract, develop, motivate and retain human capital to improve performance and drive growth.

Together, Oracle and Taleo expect to create a comprehensive cloud offering for organizations to manage their Human Resource operations and employee careers. The combination is expected to empower employees and managers to effectively manage careers throughout their entire employment, enable organizations to retain talent and optimize costs, and improve the employee experience through faster on boarding and better collaboration with team members via social media.

The Board of Directors of Taleo has unanimously approved the transaction. The transaction is expected to close mid-year 2012, subject to Taleo stockholder approval, certain regulatory approvals and other customary closing conditions.

"Human capital management has become a strategic initiative for organizations," said Thomas Kurian, Executive Vice President, Oracle Development. "Taleo's industry leading talent management cloud is an important addition to the Oracle Public Cloud."

"Taleo's integrated cloud-based talent management solutions optimize how organizations hire, manage, develop and reward their employees and gives companies the intelligence needed to capitalize on their most critical asset -- their people," said Michael Gregoire, Chairman and CEO, Taleo. "Joining forces with Oracle gives us the opportunity to better serve our customers."

More information on this announcement can be found at http://www.taleo.com/oracle.

About Taleo Taleo (NASDAQ: TLEO) helps organizations improve the performance of their business by unlocking the power of their people. Taleo is the only company to provide industry-leading solutions in every category of Talent Management. Through its cloud-based platform, Taleo optimizes recruiting, performance management, learning and compensation -- and integrates them all so managers have the insights they need to achieve talent intelligence. Customers also plug into Taleo's unique Talent Grid community to harness the power of proven best practices, millions of users, and Taleo-ready partner solutions. From small and medium sized businesses to large enterprises, more than 5,000 organizations rely on Taleo every day to pursue growth, innovation and customer success.

Forward-Looking Statements

Additional Information and Where to Find It Taleo Corporation ("Taleo") plans to file with the Securities and Exchange Commission (the "SEC") and furnish to its stockholders a proxy statement in connection with the proposed merger with Tiger Acquisition Corporation, pursuant to which Taleo would be indirectly acquired by Oracle Corporation (the "Merger"). The proxy statement will contain important information about the proposed Merger and related matters. INVESTORS AND STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT CAREFULLY WHEN IT BECOMES AVAILABLE. Investors and stockholders will be able to obtain free copies of the proxy statement and other documents filed with the SEC by Taleo through the web site maintained by the SEC at www.sec.gov, from Taleo by calling (925) 452-3120 or writing to Investor Relations at 4140 Dublin Boulevard, Suite 400, Dublin, California 94568, or by going to Taleo's Investor Relations web site at http://ir.taleo.com/financials.cfm.

Taleo and its directors and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of Taleo in connection with the proposed Merger. Information regarding the interests of these directors and executive officers in the transaction described herein and certain compensation arrangements based on or relating to the Merger will be included in the proxy statement described above. Additional information regarding these directors and executive officers is also included in Taleo's proxy statement for its 2011 Annual Meeting of Stockholders, which was filed with the SEC on April 15, 2011. This document is available free of charge at the SEC's web site at www.sec.gov, from Taleo by calling (925) 452-3120 or writing to Investor Relations at 4140 Dublin Boulevard, Suite 400, Dublin, California 94568, or by going to Taleo's Investor Relations web site at http://ir.taleo.com/financials.cfm.

Note on Forward-Looking Statements The subject document contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including but not limited to, statements regarding the expected benefits and costs of the transaction, the plans, strategies and objectives of management for future operations, and the expected closing of the proposed Merger. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those indicated in such forward-looking statements, including, but not limited to, the ability of the parties to consummate the proposed Merger, satisfaction of closing conditions precedent to the consummation of the proposed Merger, including obtaining antitrust approvals in the U.S. and other jurisdictions, as applicable, the ability of Oracle to successfully integrate Taleo's operations and employees, the ability to realize anticipated benefits of the proposed Merger, and such other risks as identified in Taleo's Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and Taleo's most recent Quarterly Report on Form 10-Q, each as filed with the SEC, which contain and identify important factors that could cause the actual results to differ materially from those contained in the forward-looking statements. Taleo assumes no obligation to update any forward-looking statement contained in the subject document.

FOR FURTHER INFORMATION PLEASE CONTACT:
        Media Contact
        Caroline Japic
        925-452-3833
        cjapic@taleo.com

        Investor Relations Contact
        Mike Magaro
        925-452-3120
        mmagaro@taleo.com

Source: Taleo Corporation


Divine Skin Q4 Tops $3 million; 2011 Revenue Reaches $9.6 million, Up 78% Over 2010 Feb 9, 2012 08:00AM

MIAMI BEACH, Fla., Feb. 9, 2012 /PRNewswire/ -- Today Divine Skin (OTC Bulletin Board: DSKX) released preliminary revenue figures for the fourth quarter, $3.1 million, up 63 percent over the same quarter of 2010 and up 48 percent over the third quarter of 2011. For the year 2011, revenue totaled $9.6 million, up 78 percent over 2010.

Divine Skin CEO Daniel Khesin said, "While we experienced nearly triple-digit growth in 2011, we are far from satisfied with this result. We believe this number will improve significantly as we continue to optimize logistics.

"Our formulas are very complex, and bringing these one-of-a-kind products to market is a challenge," he continued. "The issue is our top priority going forward, and we are very excited about our prospects for 2012."

Divine Skin had a busy year. Notable achievements include:

  • SALONS. In 2011 Divine Skin established new agreements with 19 salon distributors around the United States to sell its flagship brand, DS Laboratories. The new partners, each a leader in its market, employ a network of nearly 1,000 sales consultants who reach a combined 150,000 salons. In 2011 they penetrated 10 percent of their outlets, and in 2012 they project to have 30 percent selling the brand. Salon distribution, which represented a small fraction of sales prior to 2011, has become Divine Skin's fastest-growing segment, responsible for nearly half of its domestic business.
  • FANTASTIC SAMS. DS Laboratories installed more locations of the huge Fantastic Sams chain of salons, supplying unique product, professional training, and promotional assistance.
  • NEIMAN MARCUS. Prestigious fashion retailer Neiman Marcus picked up Divine Skin's super-premium Sigma Skin line for hair and skin.
  • WHOLE FOODS. The NutraOrigin line was tested successfully in Whole Foods, a chain of 297 retail stores in the United States plus seven in Canada and six in the United Kingdom.
  • NANOXIDIL. The company introduced a new compound, Nanoxidil, engineered to surpass minoxidil for efficacy and tolerability. It debuted in the new topical treatment Spectral.DNC-N.
  • ASTRESSIN-B. DS Laboratories became the first biotech brand to commercialize a hair-growth treatment based on astressin-B, a peptide (protein fragment) newly discovered to regrow hair on bald mice. It debuted in the new Spectral.F7.
  • API SOLUTION 9. The Polaris Research brand rolled out API Solution 9, a customizable topical kit to be sold by physicians. It delivers unprecedented concentrations of minoxidil, finasteride, and alfatradiol, and it has no direct competitor.
  • ORAL ANALGESIC. Divine Skin announced its foray into pharmaceuticals with an oral analgesic to compete with Tylenol, Advil, and aspirin. Like the company's other products, it targets the market that appreciates more advanced biotechnology.
  • NUTRAORIGIN. Expanding into nutritional supplements, Divine Skin acquired rights to NutraOrigin, with 63 formulas that can be incorporated easily into any health regimen.
  • BRAZIL. A new Brazilian distributor conducted the successful trials and earned the required certificates needed to import product into that burgeoning market of 201 million eager consumers.
  • RANBAXY LABORATORIES. Divine Skin announced a global partnership with India's largest pharmaceutical company, Ranbaxy Laboratories, to sell DS Laboratories products worldwide.
  • CAPITALIZATION. Divine Skin secured new capital through Littlebanc Advisors to be used to build mounting inventory and service expanding distribution.
  • AUDITORS. Top-30 auditing firm Cherry, Bekaert & Holland LLP began advising the company, bringing valuable experience with publicly traded manufacturers and lending greater credibility to financial statements.

About Divine Skin

Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices. The fast-growing company went public in 2009.

DS Laboratories, its flagship brand, offers high-performance topical solutions to restore growth and radiance to hair, suppress dandruff and unwanted hair, control acne, improve hygiene, and reduce cellulite and wrinkles. Bioavailability is enhanced through Nanosome encapsulation (www.dslaboratories.com).

The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and Harvey Nichols in the United Kingdom. The topical products address hair loss and other signs of aging (www.sigmaskin.com).

Polaris Research Laboratories makes high-potency minoxidil-based hair-growth formulas (www.polarisresearchlabs.com).

The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials are extracted without industrial solvents or damaging heat and are sold through premium retailers (www.thepureguild.com).

NutraOrigin blends nutritional supplements that address the health concerns expressed by consumers, including fatigue, headache, obesity, mobility, menopause, erectile dysfunction, and others. In clinical trials for the US government, its Omega line proved to enhance mental function (www.nutraorigin.com).

Contact:Abner SilvaInvestor Relations Divine Skin Inc.1.407.342.4112investors@divineskin.com

SOURCE Divine Skin Inc.


More Press Releases

View Older Stories

Feb 9, 2012 08:00AM Hexaware Technologies to Deliver Joint Customer Presentation at TDWI 2012
Feb 9, 2012 08:00AM SuccessEHS Named 2012 EHR Direct Qualified Vendor for PQRS
Feb 9, 2012 08:00AM Abzu Continues to Intersect Mineralized Gold Zones at Nangodi
Feb 9, 2012 08:00AM Robert Half Legal Survey Shows Lawyers Conducting Fewer Business Lunches
Feb 9, 2012 08:00AM Corvus Gold-New District Scale Gold Project in Quebec
Feb 9, 2012 08:00AM AMPS Builds New Orleans' First "Aeroponic" Recirculating Farm, Demonstrates Sustainable Urban Agriculture
Feb 9, 2012 08:00AM Novadx Commences Shipments of Rex Coal
Feb 9, 2012 08:00AM Vertafore AMS360 v6.0 Delivers Enhanced User Experience and Mobile Access
Feb 9, 2012 08:00AM Fjordland and Capstone Plan Aggressive Exploration Program on Tak Copper-Gold-Molybdenum Project, Central British Columbia
Feb 9, 2012 08:00AM First Point Minerals Receives Conditional Approval To List On The Toronto Stock Exchange
Feb 9, 2012 08:00AM Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
Feb 9, 2012 08:00AM Fijian Prime Minister to Announce Details of Constitutional Consultation Process
Feb 9, 2012 08:00AM Eli Manning and Venus Williams to Lead March for Babies® in Manhattan
Feb 9, 2012 08:00AM Inergetics Announces the Launch of its Private Label Channel and Executes Supply Agreement with Muscle Maker Grill Restaurants
Feb 9, 2012 08:00AM Barneys New York Debuts the Spring 2012 Womens Designer Campaign 'Tree Time'
Feb 9, 2012 08:00AM LiquiTec to Conduct Liquidation Sale of Epic Production Technologies' Surplus Assets
Feb 9, 2012 08:00AM DYMO/Mimio Names "Bridging the Gap" Technology Grant Winners
Feb 9, 2012 08:00AM VOXX International Corporation Announces Definitive Agreement to Acquire Car Communication Holding GmbH, a European Leader in Automotive Communications and Infotainment Solutions
Feb 9, 2012 08:00AM Best Western Facebook Fans Can "Be a Travel Hero" & Win a Vacation of a Lifetime for Family and Friends
Feb 9, 2012 08:00AM Fifth Lilly Oncology on Canvas Art Competition Invites All Touched by Cancer to Share Their Cancer Journeys
Feb 9, 2012 08:00AM HarperOne Announces HarperOne Selects
Feb 9, 2012 08:00AM ChinaCast Education Terminates Stockholder Rights Plan and Appointment of New Board Committee Members
Feb 9, 2012 08:00AM CVS/pharmacy's "Project Health" Will Deliver More Than $21 Million Worth of Preventive Health Screening Events Across the U.S. in 2012
Feb 9, 2012 08:00AM EchoStar Corporation Announces Conference Call for Fourth Quarter and Year End 2011 Financial Results
Feb 9, 2012 08:00AM Third Annual Nun Run Takes Off March 10, Becomes 'A Good Habit' in Arizona, U.S. and Abroad
Feb 9, 2012 08:00AM Ambit Biosciences to Present at Two Upcoming Investor Conferences
Feb 9, 2012 08:00AM China Nutrifruit Schedules Conference Call to Discuss Third Quarter Fiscal Year 2012 Results
Feb 9, 2012 08:00AM AdSafe Media Introduces Foreign Language Support to its Suite of Brand Protection, Ad Verification, and Ad Engagement Products
Feb 9, 2012 08:00AM Home Value Declines Pick Up in Fourth Quarter, But Zillow Forecasts Smaller Declines in 2012
Feb 9, 2012 08:00AM Agilysys Reports Unaudited Fiscal 2012 Third-Quarter and Nine-Month Results
Feb 9, 2012 08:00AM KKR & Co. L.P. Announces Fourth Quarter and Full Year 2011 Results
Feb 9, 2012 08:00AM Shengkai Innovations, Inc. Schedules Conference Call to Discuss FY2012 Second Quarter Results on February 10th
Feb 9, 2012 08:00AM Asta Funding, Inc. Announces Earnings for First Quarter Fiscal 2012
Feb 9, 2012 08:00AM IIROC: Halt, Kenna Capital Corp.
Feb 9, 2012 08:00AM Lyris, Inc., Reports Second Quarter 2012 Results
Feb 9, 2012 08:00AM ProPhotonix Adds New HL65051DG Laser Diode From Opnext to Its Laser Diode Line-Up
Feb 9, 2012 08:00AM Solutia Introduces New Saflex® Structural Interlayer for Architectural Laminated Glass Applications
Feb 9, 2012 08:00AM Tekmira Announces USPTO Issuance of Key Patents Broadly Covering LNP Formulations and Mitigation of Immune Stimulation
Feb 9, 2012 08:00AM Hands of the World's Largest Tower Clock Turn on DEVA Bearings From Federal-Mogul
Feb 9, 2012 08:00AM Sandos Hotels & Resorts Announces the Addition of Sandos Cancun Luxury Experience Resort
Feb 9, 2012 08:00AM Asia Pacific Wire & Cable Corporation Retains MZ Group as Its Investor Relations Advisor
Feb 9, 2012 08:00AM First Savings Financial Group, Inc. to Expand Its Southern Indiana Franchise by Acquiring Branch Offices From First Federal Savings Bank of Elizabethtown
Feb 9, 2012 08:00AM Unisys Helps Isle of Man Government Reduce Costs and Transform Public Services by Modernizing Server Environment and Moving to Hybrid Cloud
Feb 9, 2012 08:00AM Deloitte Consumer Spending Index Falls on Sharp Declines in the Housing Market; Consumer Spending to Face Economic Headwinds in 2012
Feb 9, 2012 08:00AM Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2011
Feb 9, 2012 08:00AM Veloxis Pharmaceuticals to Present at 14th Annual BIO CEO & Investor Conference
Feb 9, 2012 08:00AM NovaBay Pharmaceuticals Provides Business Update and 2012 Outlook
Feb 9, 2012 08:00AM Endologix Completes Enrollment in PEVAR Randomized Trial
Feb 9, 2012 08:00AM David Colford Appointed as Geeknet Media's Executive Vice President of Global Sales and Operations
Feb 9, 2012 08:00AM Mazda Expands Local Presence with New Parts Distribution Center
View Older Stories